Literature DB >> 20196645

The early fracture hematoma and its potential role in fracture healing.

Paula Kolar1, Katharina Schmidt-Bleek, Hanna Schell, Timo Gaber, Daniel Toben, Gerhard Schmidmaier, Carsten Perka, Frank Buttgereit, Georg N Duda.   

Abstract

Research regarding the potency and potential of the fracture hematoma has begun to receive increasing attention. However, currently there is a paucity of relevant literature on the capability and composition of the fracture hematoma. This review briefly summarizes the regenerative fracture healing process and the close interplay between the skeletal and immune systems. The role of immune cells in wound healing is also discussed to clarify their involvement in immunological processes during regeneration. We attempt to describe the current state of knowledge regarding the fracture hematoma as the initial stage of the regenerative process of fracture healing. The review discusses how a better understanding of immune reactions in the hematoma may have implications for bone tissue engineering strategies. We conclude the review by emphasizing how additional investigations of the initial phase of healing will allow us to better differentiate between deleterious and beneficial aspects of inflammation, thereby facilitating improved fracture treatment strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20196645     DOI: 10.1089/ten.TEB.2009.0687

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  105 in total

1.  Student Award for Outstanding Research Winner in the Ph.D. Category for the 9th World Biomaterials Congress, Chengdu, China, June 1-5, 2012: The interplay of bone-like extracellular matrix and TNF-α signaling on in vitro osteogenic differentiation of mesenchymal stem cells.

Authors:  Paschalia M Mountziaris; Stephanie N Tzouanas; Antonios G Mikos
Journal:  J Biomed Mater Res A       Date:  2012-02-18       Impact factor: 4.396

2.  Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds.

Authors:  Paschalia M Mountziaris; E Dennis Lehman; Ioannis Mountziaris; David C Sing; F Kurtis Kasper; Antonios G Mikos
Journal:  J Biomater Sci Polym Ed       Date:  2013-06-08       Impact factor: 3.517

Review 3.  Harnessing and modulating inflammation in strategies for bone regeneration.

Authors:  Paschalia M Mountziaris; Patrick P Spicer; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

Review 4.  Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis.

Authors:  Katharina Schmidt-Bleek; Brian J Kwee; David J Mooney; Georg N Duda
Journal:  Tissue Eng Part B Rev       Date:  2015-04-01       Impact factor: 6.389

5.  Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas.

Authors:  Paula Hoff; T Gaber; K Schmidt-Bleek; U Sentürk; C L Tran; K Blankenstein; S Lütkecosmann; J Bredahl; H J Schüler; P Simon; G Wassilew; F Unterhauser; G R Burmester; G Schmidmaier; C Perka; G N Duda; F Buttgereit
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

Review 6.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

7.  Recent Advances in Biomaterials for the Treatment of Bone Defects.

Authors:  Le-Yi Zhang; Qing Bi; Chen Zhao; Jin-Yang Chen; Mao-Hua Cai; Xiao-Yi Chen
Journal:  Organogenesis       Date:  2020-08-16       Impact factor: 2.500

Review 8.  Inflammation, mesenchymal stem cells and bone regeneration.

Authors:  Hongrui Liu; Dongfang Li; Yi Zhang; Minqi Li
Journal:  Histochem Cell Biol       Date:  2018-02-12       Impact factor: 4.304

9.  Immunological characterization of the early human fracture hematoma.

Authors:  Paula Hoff; T Gaber; C Strehl; K Schmidt-Bleek; A Lang; D Huscher; G R Burmester; G Schmidmaier; C Perka; G N Duda; F Buttgereit
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

10.  Interleukin 1β and tumor necrosis factor α promote hFOB1.19 cell viability via activating AP1.

Authors:  Hongliang Ying; Qiang Li; Changfu Zhao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.